Swedish researchers have created a questionnaire test for home use that quickly identifies high risk of heart attack.
FDA Staff Highly Skeptical of Confirmatory Data on KRAS Inhibitor in NSCLC
Ahead of a meeting of the Oncologic Drugs Advisory Committee on Thursday, FDA reviewers raised a host of concerns about the confirmatory trial data for
October 5, 2023